PMID: 8596318Mar 2, 1996Paper

Prevalence and cost of alternative medicine in Australia

Lancet
A H MacLennanA W Taylor

Abstract

To determine the prevalence and cost of alternative medicines and alternative practitioner use in an Australian population. We conducted a representative population survey of persons aged 15 or older living in South Australia, which required 3004 personal interviews. We assessed the rates of use and types of alternative medicine and therapists used by this population in 1993, and correlations with other demographic and medical variables. The overall use of at least one non-medically prescribed alternative medicine (excluding calcium, iron and prescribed vitamins) was 48.5%. The users were more likely to be perimenopausal females, better educated, have a higher alcohol intake, be of normal weight and more likely to be employed than non-users. 20.3% of respondents had visited at least one alternative practitioner, most commonly chiropractors (15%). The users of alternative practitioners were more likely to be younger, live in the country and be overweight. Women were more likely to consult naturopaths, iridiologists, and reflexologists than men. Extrapolation of the costs to the Australian population gives a natural expenditure in 1993, for alternative medicines, of $621 million (Australian dollars) and for alternative therapists...Continue Reading

References

Apr 22, 1995·BMJ : British Medical Journal·P A De Smet
Jul 9, 1994·Lancet·J CuiI Björkhem
Jun 26, 1993·Lancet·E Ernst
Jul 17, 1993·Lancet·L PerharicV Murray
Feb 19, 1994·BMJ : British Medical Journal·R ChenoyP F Morse
Feb 1, 1994·Social Science & Medicine·A O'Neill
Jan 28, 1993·The New England Journal of Medicine·D M EisenbergT L Delbanco

❮ Previous
Next ❯

Citations

Nov 27, 1998·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·C Ramos-RemusM E Suarez-Almazor
Jul 3, 2007·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·C A K Y ChongA M Cheung
Mar 28, 2009·Journal of Neurology·Annett Apel-Neu, U K Zettl
Nov 6, 2008·Clinical Rheumatology·Simon M ChatfieldLionel Schachna
Apr 22, 2011·Chinese Journal of Integrative Medicine·Daniel WeberGeoffrey M Currie
Jul 12, 2005·Complementary Therapies in Clinical Practice·Trisha Dunning
May 24, 2005·Complementary Therapies in Medicine·M K LimJ Y Heng
Feb 10, 2004·The Journal of Allergy and Clinical Immunology·Kamal SrivastavaXiu-Min Li
Apr 1, 2005·Journal of Manipulative and Physiological Therapeutics·Ian D Coulter, Paul G Shekelle
Jun 16, 2001·Clinical Biochemistry·A PopatM G Neuman
Apr 24, 2001·Journal of Psychosomatic Research·M Dello BuonoD De Leo
Dec 4, 2003·Journal of Psychosomatic Research·Torsten SchäferJohannes Ring
Oct 26, 2001·Journal of the Neurological Sciences·M WasnerG D Borasio
Aug 31, 1999·Survey of Ophthalmology·C E Margo
Mar 5, 2002·Ophthalmology·Douglas J RheeL Jay Katz
Nov 5, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Thomas MartinNikolaos Zamboglou
Nov 15, 2000·Social Science & Medicine·G EasthopeG Gill
Sep 11, 2002·Social Science & Medicine·Fuschia M Sirois, Mary L Gick
Sep 17, 2002·Social Science & Medicine·R Frank
Jan 16, 2004·Social Science & Medicine·Amanda Kenny, Stephen Duckett
Feb 6, 1999·The Journal of Family Practice·W S Strouse
Mar 19, 2003·Reproductive Toxicology·Adriane Fugh-Berman, Fredi Kronenberg
Jan 10, 2002·Journal of Clinical Epidemiology·Ahmad Al-WindiSvärdsudd Kurt
May 17, 2000·Journal of Clinical Epidemiology·M H PittlerE Ernst
Jun 26, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E CrocettiE Buiatti
Feb 16, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E Ernst, B R Cassileth
Feb 16, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L G Walker, J Anderson
May 17, 2000·Complementary Therapies in Medicine·E Ernst, A White
Apr 2, 2003·Complementary Therapies in Medicine·F V O'Callaghan, N Jordan
Apr 2, 2003·Complementary Therapies in Medicine·M E HylandC Westoby

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.